Cargando…
Medicaid prescription limits and their implications for naloxone accessibility
BACKGROUND: Expanding access to and utilization of naloxone is a vitally important harm reduction strategy for preventing opioid overdose deaths, particularly in vulnerable populations like Medicaid beneficiaries. The objective of this study was to characterize the landscape of monthly prescription...
Autores principales: | Roberts, Andrew W., Look, Kevin A., Trull, Grace, Carpenter, Delesha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568500/ https://www.ncbi.nlm.nih.gov/pubmed/33309522 http://dx.doi.org/10.1016/j.drugalcdep.2020.108355 |
Ejemplares similares
-
Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts et al., 2021)
por: Talbert, Jeffery, et al.
Publicado: (2021) -
Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid
por: Messinger, John C, et al.
Publicado: (2022) -
Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018) -
Exploring the impact of brief training on student pharmacists' naloxone communication skills
por: Jankowski, Kelly, et al.
Publicado: (2023) -
Medicaid prescription limits: policy trends and comparative impact on utilization
por: Lieberman, Daniel A., et al.
Publicado: (2016)